glutathione parkinson's disease therapy perlmutter The ongoing pursuit of neuroprotective therapies in Parkinson Enhanced accumulation of reduced glutathione
Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease New research suggests Parkinson's disease may be better understood and diagnosed by its underlying biology rather than symptoms alone. Scientists are exploring how biomarkers and disease mechanisms could redefine Parkinson's Recent advances in natural products targeting synuclein aggregation or clearance in Parkinson's disease ScienceDirect Joel Perlmutter, MD Neurology Washington University in St. Louis
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


